诉讼案件概述 - 罗森律师事务所提醒在2022年2月15日至2025年9月24日期间购买Freeport-McMoRan公司证券的投资者注意2026年1月12日的首席原告截止日期 [1] - 一项针对Freeport-McMoRan的证券集体诉讼已经提起 [3] 诉讼指控内容 - 指控称被告做出了虚假和/或误导性陈述及/或未能披露以下信息 [5] - Freeport-McMoRan未能充分确保其印度尼西亚Grasberg Block Cave矿场的安全 [5] - 缺乏适当的安全预防措施构成了可预见的导致工人死亡的风险 [5] - 这构成了未披露的监管、诉讼和声誉风险的增加 [5] - 因此被告关于公司业务、运营和前景的陈述在所有相关时间都存在重大虚假和误导性及/或缺乏合理依据 [5] - 当真实情况进入市场时投资者遭受了损失 [5] 律师事务所信息 - 罗森律师事务所是一家专注于证券集体诉讼和股东衍生诉讼的全球投资者权益律师事务所 [4] - 该所曾达成针对一家中国公司的史上最大证券集体诉讼和解 [4] - 该所因2017年证券集体诉讼和解数量被ISS证券集体诉讼服务评为第一名 [4] - 自2013年以来该所每年排名均在前四 [4] - 该所为投资者追回了数亿美元 [4] - 仅在2019年该所就为投资者确保了超过4.38亿美元 [4]

NEW YORK, Dec. 20, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Telix Pharmaceuticals Ltd. (NASDAQ: TLX) between February 21, 2025 and August 28, 2025, both dates inclusive (the “Class Period”), of the important January 9, 2026 lead plaintiff deadline in the securities class action first filed by the Firm. SO WHAT: If you purchased Telix securities during the Class Period you may be entitled to compensation without payment of any out o ...

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Skye To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Skye between November 4, 2024 and October 3, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK, Dec. 20, 2025 (GLOBE NEWSWIRE) -- Faruqi & Far ...

公司业绩与财务表现 - 公司2025年第三季度财报显示可比门店增长较上一季度下降4.3% [6] - 管理层预计第四季度可比销售增长仅为0%至2%并下调全年增长预期从上一季度的7.5%-9%降至7% [6] - 业绩公布后公司股价每股下跌22.64美元开盘报81.91美元每股 [6] 公司声明与市场沟通 - 公司及其高管被指控向投资者发布虚假和/或误导性陈述及/或未披露重大不利事实 [5] - 指控称公司提供了过于积极的声明但隐瞒了关于其增长潜力的真实状况 [5] - 公司此前曾表示其业务具有“韧性几乎不受宏观经济影响”但最新业绩将疲软归因于艰难的同比对比和消费疲软 [6] 法律诉讼进展 - 针对公司的联邦证券集体诉讼已提起投资者需在2026年1月26日前申请成为首席原告 [3] - 诉讼指控公司违反联邦证券法导致原告和其他股东以被人为抬高价格购买公司证券 [5] - 律师事务所正在调查针对公司的潜在索赔并鼓励知情者提供信息 [8]

NEW YORK, Dec. 19, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Skye Bioscience, Inc. (NASDAQ: SKYE) between November 4, 2024 and October 3, 2025, both dates inclusive (the “Class Period”), of the important January 16, 2026 lead plaintiff deadline. SO WHAT: If you purchased Skye securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement ...

NEW YORK, Dec. 19, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Perrigo Company plc (NYSE: PRGO) between February 27, 2023 and November 4, 2025, both dates inclusive (the “Class Period”), of the important January 16, 2026 lead plaintiff deadline. SO WHAT: If you purchased Perrigo securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangemen ...

NEW YORK, Dec. 19, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Synopsys, Inc. (NASDAQ: SNPS) between December 4, 2024 and September 9, 2025, both dates inclusive (the “Class Period”), of the important December 30, 2025 lead plaintiff deadline. SO WHAT: If you purchased Synopsys securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement ...

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In StubHub To Contact Him Directly To Discuss Their Options If you purchased or otherwise acquired stock of StubHub pursuant and/or traceable to StubHub’s registration statement for the initial public offering held on or about September 17, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also ...

案件概述 - 罗森律师事务所提醒在2025年2月21日至2025年8月28日期间购买Telix Pharmaceuticals Ltd (NASDAQ: TLX) 证券的投资者 关于2026年1月9日的重要首席原告截止日期 [1] - 一项针对Telix的证券集体诉讼已经提起 投资者可能有权通过风险代理收费安排获得赔偿 而无需支付任何自付费用 [2][3] 诉讼指控详情 - 指控被告在整个集体诉讼期间做出了重大虚假和/或误导性陈述 和/或未能披露 [5] - 具体指控包括 被告严重夸大了Telix在前列腺癌治疗候选药物方面取得的进展 [5] - 被告严重夸大了Telix的供应链及合作伙伴的质量 [5] - 因此 被告关于Telix业务 运营和前景的陈述在所有相关时间均存在重大虚假和误导性 和/或缺乏合理依据 [5] - 诉讼称 当真实情况进入市场时 投资者遭受了损失 [5] 律师事务所信息 - 罗森律师事务所是一家全球投资者权益律师事务所 专注于证券集体诉讼和股东衍生诉讼 [4] - 该所曾达成针对中国公司的史上最大证券集体诉讼和解 并在2017年被ISS证券集体诉讼服务评为和解数量第一 [4] - 自2013年以来 该所每年排名前四 已为投资者追回数亿美元 仅在2019年就为投资者确保了超过4.38亿美元 [4]

NEW YORK, Dec. 17, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Avantor, Inc. (NYSE: AVTR) between March 5, 2024 and October 28, 2025, both dates inclusive (the “Class Period”), of the important December 29, 2025 lead plaintiff deadline. SO WHAT: If you purchased Avantor common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WH ...